These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23270475)

  • 1. Cutaneous leishmaniasis in a patient receiving infliximab.
    Hernández-Torres A; García-Vázquez E; Frías-Iniesta J; Herrero-Martínez JA; Gómez-Gómez J
    Scand J Infect Dis; 2013 Jul; 45(7):567-9. PubMed ID: 23270475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe.
    Zanger P; Kötter I; Kremsner PG; Gabrysch S
    Clin Microbiol Infect; 2012 Jul; 18(7):670-6. PubMed ID: 21985586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized Cutaneous Leishmaniasis due to Leishmania infantum in a Patient Treated with Infliximab.
    Hakimi S; Rivière S; Del Giudice P; Dereure J; Le Quellec A
    Dermatology; 2010; 220(1):63-5. PubMed ID: 19907139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor necrosis factor-alpha therapy provokes latent leishmaniasis in a patient with rheumatoid arthritis.
    Franklin G; Greenspan J; Chen S
    Ann Clin Lab Sci; 2009; 39(2):192-5. PubMed ID: 19429808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
    Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
    Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical presentation of histoplasmosis in a patient with psoriasis and psoriatic arthritis on infliximab therapy.
    Kamili Qu; Menter A
    J Drugs Dermatol; 2010 Jan; 9(1):57-60. PubMed ID: 20120426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary leprosy infection in a patient with psoriasis during treatment with infliximab.
    Teixeira FM; Vasconcelos LM; Rola Cde A; Prata de Almeida TL; Valença JT; Nagao-Dias AT
    J Clin Rheumatol; 2011 Aug; 17(5):269-71. PubMed ID: 21778902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infectious complications in patients treated with anti-TNF-alpha: two cases of leishmaniasis].
    Bousquet E; Mura F; Villain M; Rivière S; Konate A; Schneider C
    J Fr Ophtalmol; 2012 Nov; 35(9):695-9. PubMed ID: 22925844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
    Smith CH; Jackson K; Bashir SJ; Perez A; Chew AL; Powell AM; Wain M; Barker JN
    Br J Dermatol; 2006 Jul; 155(1):160-9. PubMed ID: 16792769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study.
    Fouache D; Goëb V; Massy-Guillemant N; Avenel G; Bacquet-Deschryver H; Kozyreff-Meurice M; Ménard JF; Muraine M; Savoye G; Le Loët X; Tharasse C; Vittecoq O
    Rheumatology (Oxford); 2009 Jul; 48(7):761-4. PubMed ID: 19395543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists.
    Tubach F; Ravaud P; Salmon-Céron D; Petitpain N; Brocq O; Grados F; Guillaume JC; Leport J; Roudaut A; Solau-Gervais E; Lemann M; Mariette X; Lortholary O;
    Clin Infect Dis; 2006 Nov; 43(10):e95-100. PubMed ID: 17051484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab.
    Mueller MC; Fleischmann E; Grunke M; Schewe S; Bogner JR; Löscher T
    Am J Trop Med Hyg; 2009 Jul; 81(1):52-4. PubMed ID: 19556566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-alpha antagonists.
    Gottlieb GS; Lesser CF; Holmes KK; Wald A
    Clin Infect Dis; 2003 Sep; 37(6):838-40. PubMed ID: 12955647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects and management of cutaneous leishmaniasis in rheumatoid patients treated with TNF-α antagonists.
    Neumayr AL; Morizot G; Visser LG; Lockwood DN; Beck BR; Schneider S; Bellaud G; Cordoliani F; Foulet F; Laffitte EA; Buffet P; Blum JA
    Travel Med Infect Dis; 2013; 11(6):412-20. PubMed ID: 23972958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical cutaneous leishmaniasis in two patients receiving low-dose methotrexate.
    Saha M; Shipley D; McBride S; Kennedy C; Vega-Lopez F
    Br J Dermatol; 2006 Oct; 155(4):830-3. PubMed ID: 16965437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous leishmaniasis in a patient with ulcerative colitis under treatment with infliximab].
    Fernández ML; Ramírez F; García E
    Gastroenterol Hepatol; 2015 Nov; 38(9):564-5. PubMed ID: 25888288
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease.
    Marehbian J; Arrighi HM; Hass S; Tian H; Sandborn WJ
    Am J Gastroenterol; 2009 Oct; 104(10):2524-33. PubMed ID: 19532125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression.
    Bosch-Nicolau P; Ubals M; Salvador F; Sánchez-Montalvá A; Aparicio G; Erra A; Martinez de Salazar P; Sulleiro E; Molina I
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007708. PubMed ID: 31469834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.